Decheng Capital LLC

Q2 2025 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    25

  • Value ($000)

    $395,968

  • Date Filed
    08/13/2025
  • Form type
    13F-HR
  • CIK
    0002010850
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CGON
CGON

CG ONCOLOGY INC

COM
156944100
$165.66M
42 %

6,371,669

---

AARDVARK THERAPEUTICS INC

COM
002942100
$52.96M
13 %

3,917,299

NUVB
NUVB

Nuvation Bio Inc.

COM
67080N101
$50.61M
13 %

25,954,439

---

Upstream Bio Inc.

COM
91678A107
$36.07M
9 %

3,285,293

---

NEWAMSTERDAM PHARMA CO NV

COM
N62509109
$13.94M
4 %

770,000

---

BeyondSpring Inc.

SHS
G10830100
$10.65M
3 %

4,531,481

---

MERUS NV

COM
N5749R100
$9.95M
3 %

189,098

KRYS
KRYS

KRYSTAL BIOTECH INC

COM
501147102
$9.07M
2 %

66,000

---

MOONLAKE IMMUNOTHERAPEUTICS

COM
G4444C102
$8.57M
2 %

181,600

RVMD
RVMD

REVOLUTION MEDICINES INC(NSM)

COM
76155X100
$8.31M
2 %

226,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 25